Working… Menu

Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis (OPAL BALANCE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01976364
Recruitment Status : Completed
First Posted : November 5, 2013
Last Update Posted : October 3, 2019
Information provided by (Responsible Party):

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : May 20, 2019
Actual Study Completion Date : May 20, 2019